Click for best price
Depression Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 17630 million
|
Forecast Market size by 2029 |
US$ 21350 million
|
| Growth Rate |
CAGR of 2.8% |
Number of Pages |
62 Pages |
Depression is a mental health issue. It?s a condition that starts most often in early adulthood. It?s also more common in women. However, anyone at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as well. Each drug used to treat depression works by balancing certain chemicals in your brain called neurotransmitters. Depression Drugs is drugs used for Depression.
This report aims to provide a comprehensive presentation of the global market for Depression Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Depression Drugs. This report contains market size and forecasts of Depression Drugs in global, including the following market information:
Global top five companies in 2022 (%)
The global Depression Drugs market was valued at US$ 17630 million in 2022 and is projected to reach US$ 21350 million by 2029, at a CAGR of 2.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Depression Drugs key players include Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, Lundbeck, etc. Global top five manufacturers hold a share over 35%.
North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share about 50%.
In terms of product, SSRIs is the largest segment, with a share over 45%. And in terms of application, the largest application is Hospitals, followed by Clinics, etc.
We surveyed the Depression Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Depression Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Depression Drugs Market Segment Percentages, by Type, 2022 (%)
Global Depression Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Depression Drugs Market Segment Percentages, by Application, 2022 (%)
Global Depression Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Depression Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Depression Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Depression Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Intellipharmaceutics
- Pfizer
- Eli Lilly
- Astrazeneca
- Lundbeck
- Allergan
- GSK
- Otsuka Pharmaceutical
- Takeda
- NHU Group
- Shionogi
- APOTEX
- Kanghong Pharma
- HUAHAI
- Outline of Major Chapters:
- Chapter 1: Introduces the definition of Depression Drugs, market overview.
- Chapter 2: Global Depression Drugs market size in revenue.
- Chapter 3: Detailed analysis of Depression Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Depression Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Depression Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 17630 million
|
| Forecast Market size by 2029 |
US$ 21350 million
|
| Growth Rate |
CAGR of 2.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Depression Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Depression Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Depression Drugs Overall Market Size
2.1 Global Depression Drugs Market Size: 2022 VS 2029
2.2 Global Depression Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Depression Drugs Players in Global Market
3.2 Top Global Depression Drugs Companies Ranked by Revenue
3.3 Global Depression Drugs Revenue by Companies
3.4 Top 3 and Top 5 Depression Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Depression Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Depression Drugs Players in Global Market
3.6.1 List of Global Tier 1 Depression Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Depression Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Depression Drugs Market Size Markets, 2022 & 2029
4.1.2 SSRIs
4.1.3 SNRIs
4.1.4 Others
4.2 By Type - Global Depression Drugs Revenue & Forecasts
4.2.1 By Type - Global Depression Drugs Revenue, 2018-2023
4.2.2 By Type - Global Depression Drugs Revenue, 2024-2029
4.2.3 By Type - Global Depression Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Depression Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Depression Drugs Revenue & Forecasts
5.2.1 By Application - Global Depression Drugs Revenue, 2018-2023
5.2.2 By Application - Global Depression Drugs Revenue, 2024-2029
5.2.3 By Application - Global Depression Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Depression Drugs Market Size, 2022 & 2029
6.2 By Region - Global Depression Drugs Revenue & Forecasts
6.2.1 By Region - Global Depression Drugs Revenue, 2018-2023
6.2.2 By Region - Global Depression Drugs Revenue, 2024-2029
6.2.3 By Region - Global Depression Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Depression Drugs Revenue, 2018-2029
6.3.2 US Depression Drugs Market Size, 2018-2029
6.3.3 Canada Depression Drugs Market Size, 2018-2029
6.3.4 Mexico Depression Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Depression Drugs Revenue, 2018-2029
6.4.2 Germany Depression Drugs Market Size, 2018-2029
6.4.3 France Depression Drugs Market Size, 2018-2029
6.4.4 U.K. Depression Drugs Market Size, 2018-2029
6.4.5 Italy Depression Drugs Market Size, 2018-2029
6.4.6 Russia Depression Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Depression Drugs Market Size, 2018-2029
6.4.8 Benelux Depression Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Depression Drugs Revenue, 2018-2029
6.5.2 China Depression Drugs Market Size, 2018-2029
6.5.3 Japan Depression Drugs Market Size, 2018-2029
6.5.4 South Korea Depression Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Depression Drugs Market Size, 2018-2029
6.5.6 India Depression Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Depression Drugs Revenue, 2018-2029
6.6.2 Brazil Depression Drugs Market Size, 2018-2029
6.6.3 Argentina Depression Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Depression Drugs Revenue, 2018-2029
6.7.2 Turkey Depression Drugs Market Size, 2018-2029
6.7.3 Israel Depression Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Depression Drugs Market Size, 2018-2029
6.7.5 UAE Depression Drugs Market Size, 2018-2029
7 Depression Drugs Companies Profiles
7.1 Intellipharmaceutics
7.1.1 Intellipharmaceutics Company Summary
7.1.2 Intellipharmaceutics Business Overview
7.1.3 Intellipharmaceutics Depression Drugs Major Product Offerings
7.1.4 Intellipharmaceutics Depression Drugs Revenue in Global Market (2018-2023)
7.1.5 Intellipharmaceutics Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Depression Drugs Major Product Offerings
7.2.4 Pfizer Depression Drugs Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Depression Drugs Major Product Offerings
7.3.4 Eli Lilly Depression Drugs Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Astrazeneca
7.4.1 Astrazeneca Company Summary
7.4.2 Astrazeneca Business Overview
7.4.3 Astrazeneca Depression Drugs Major Product Offerings
7.4.4 Astrazeneca Depression Drugs Revenue in Global Market (2018-2023)
7.4.5 Astrazeneca Key News & Latest Developments
7.5 Lundbeck
7.5.1 Lundbeck Company Summary
7.5.2 Lundbeck Business Overview
7.5.3 Lundbeck Depression Drugs Major Product Offerings
7.5.4 Lundbeck Depression Drugs Revenue in Global Market (2018-2023)
7.5.5 Lundbeck Key News & Latest Developments
7.6 Allergan
7.6.1 Allergan Company Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Depression Drugs Major Product Offerings
7.6.4 Allergan Depression Drugs Revenue in Global Market (2018-2023)
7.6.5 Allergan Key News & Latest Developments
7.7 GSK
7.7.1 GSK Company Summary
7.7.2 GSK Business Overview
7.7.3 GSK Depression Drugs Major Product Offerings
7.7.4 GSK Depression Drugs Revenue in Global Market (2018-2023)
7.7.5 GSK Key News & Latest Developments
7.8 Otsuka Pharmaceutical
7.8.1 Otsuka Pharmaceutical Company Summary
7.8.2 Otsuka Pharmaceutical Business Overview
7.8.3 Otsuka Pharmaceutical Depression Drugs Major Product Offerings
7.8.4 Otsuka Pharmaceutical Depression Drugs Revenue in Global Market (2018-2023)
7.8.5 Otsuka Pharmaceutical Key News & Latest Developments
7.9 Takeda
7.9.1 Takeda Company Summary
7.9.2 Takeda Business Overview
7.9.3 Takeda Depression Drugs Major Product Offerings
7.9.4 Takeda Depression Drugs Revenue in Global Market (2018-2023)
7.9.5 Takeda Key News & Latest Developments
7.10 NHU Group
7.10.1 NHU Group Company Summary
7.10.2 NHU Group Business Overview
7.10.3 NHU Group Depression Drugs Major Product Offerings
7.10.4 NHU Group Depression Drugs Revenue in Global Market (2018-2023)
7.10.5 NHU Group Key News & Latest Developments
7.11 Shionogi
7.11.1 Shionogi Company Summary
7.11.2 Shionogi Business Overview
7.11.3 Shionogi Depression Drugs Major Product Offerings
7.11.4 Shionogi Depression Drugs Revenue in Global Market (2018-2023)
7.11.5 Shionogi Key News & Latest Developments
7.12 APOTEX
7.12.1 APOTEX Company Summary
7.12.2 APOTEX Business Overview
7.12.3 APOTEX Depression Drugs Major Product Offerings
7.12.4 APOTEX Depression Drugs Revenue in Global Market (2018-2023)
7.12.5 APOTEX Key News & Latest Developments
7.13 Kanghong Pharma
7.13.1 Kanghong Pharma Company Summary
7.13.2 Kanghong Pharma Business Overview
7.13.3 Kanghong Pharma Depression Drugs Major Product Offerings
7.13.4 Kanghong Pharma Depression Drugs Revenue in Global Market (2018-2023)
7.13.5 Kanghong Pharma Key News & Latest Developments
7.14 HUAHAI
7.14.1 HUAHAI Company Summary
7.14.2 HUAHAI Business Overview
7.14.3 HUAHAI Depression Drugs Major Product Offerings
7.14.4 HUAHAI Depression Drugs Revenue in Global Market (2018-2023)
7.14.5 HUAHAI Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Depression Drugs Market Opportunities & Trends in Global Market
Table 2. Depression Drugs Market Drivers in Global Market
Table 3. Depression Drugs Market Restraints in Global Market
Table 4. Key Players of Depression Drugs in Global Market
Table 5. Top Depression Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Depression Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Depression Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Depression Drugs Product Type
Table 9. List of Global Tier 1 Depression Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Depression Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Depression Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Depression Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Depression Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Depression Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Depression Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Depression Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Depression Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Depression Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Depression Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Depression Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Depression Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Depression Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Depression Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Depression Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Depression Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Depression Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Depression Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Depression Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Depression Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Intellipharmaceutics Company Summary
Table 31. Intellipharmaceutics Depression Drugs Product Offerings
Table 32. Intellipharmaceutics Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Intellipharmaceutics Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Depression Drugs Product Offerings
Table 36. Pfizer Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Eli Lilly Company Summary
Table 39. Eli Lilly Depression Drugs Product Offerings
Table 40. Eli Lilly Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly Key News & Latest Developments
Table 42. Astrazeneca Company Summary
Table 43. Astrazeneca Depression Drugs Product Offerings
Table 44. Astrazeneca Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Astrazeneca Key News & Latest Developments
Table 46. Lundbeck Company Summary
Table 47. Lundbeck Depression Drugs Product Offerings
Table 48. Lundbeck Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Lundbeck Key News & Latest Developments
Table 50. Allergan Company Summary
Table 51. Allergan Depression Drugs Product Offerings
Table 52. Allergan Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Allergan Key News & Latest Developments
Table 54. GSK Company Summary
Table 55. GSK Depression Drugs Product Offerings
Table 56. GSK Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. GSK Key News & Latest Developments
Table 58. Otsuka Pharmaceutical Company Summary
Table 59. Otsuka Pharmaceutical Depression Drugs Product Offerings
Table 60. Otsuka Pharmaceutical Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Otsuka Pharmaceutical Key News & Latest Developments
Table 62. Takeda Company Summary
Table 63. Takeda Depression Drugs Product Offerings
Table 64. Takeda Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Takeda Key News & Latest Developments
Table 66. NHU Group Company Summary
Table 67. NHU Group Depression Drugs Product Offerings
Table 68. NHU Group Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. NHU Group Key News & Latest Developments
Table 70. Shionogi Company Summary
Table 71. Shionogi Depression Drugs Product Offerings
Table 72. Shionogi Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Shionogi Key News & Latest Developments
Table 74. APOTEX Company Summary
Table 75. APOTEX Depression Drugs Product Offerings
Table 76. APOTEX Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. APOTEX Key News & Latest Developments
Table 78. Kanghong Pharma Company Summary
Table 79. Kanghong Pharma Depression Drugs Product Offerings
Table 80. Kanghong Pharma Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Kanghong Pharma Key News & Latest Developments
Table 82. HUAHAI Company Summary
Table 83. HUAHAI Depression Drugs Product Offerings
Table 84. HUAHAI Depression Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. HUAHAI Key News & Latest Developments
List of Figures
Figure 1. Depression Drugs Segment by Type in 2022
Figure 2. Depression Drugs Segment by Application in 2022
Figure 3. Global Depression Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Depression Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Depression Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Depression Drugs Revenue in 2022
Figure 8. By Type - Global Depression Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Depression Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Depression Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Depression Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Depression Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Depression Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Depression Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Depression Drugs Revenue Market Share, 2018-2029
Figure 16. US Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Depression Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Depression Drugs Revenue Market Share, 2018-2029
Figure 28. China Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Depression Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Depression Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Depression Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Intellipharmaceutics Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Astrazeneca Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Lundbeck Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Allergan Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. GSK Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Otsuka Pharmaceutical Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Takeda Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. NHU Group Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Shionogi Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. APOTEX Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Kanghong Pharma Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. HUAHAI Depression Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
